BlackRock, Inc. (BLK) 13D/13G Filings for Nurix Therapeutics, Inc. (NRIX)

BlackRock, Inc. 13D and 13G filings for Nurix Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2025-04-23
8:57 pm
Purchase		 2025-03-31 13G Nurix Therapeutics, Inc.
NRIX		 BlackRock Inc.
BLK		 6,284,116
8.200%		 241,966increase
(+4.00%)		 Filing
2024-06-07
1:30 pm
Purchase		 2024-05-31 13G Nurix Therapeutics, Inc.
NRIX		 BlackRock Inc.
BLK		 6,042,150
10.200%		 1,398,414increase
(+30.11%)		 Filing
2024-01-24
2:27 pm
Purchase		 2023-12-31 13G Nurix Therapeutics, Inc.
NRIX		 BlackRock Inc.
BLK		 4,643,736
9.600%		 501,208increase
(+12.10%)		 Filing
2023-01-25
10:36 am
Purchase		 2022-12-31 13G Nurix Therapeutics, Inc.
NRIX		 BlackRock Inc.
BLK		 4,142,528
8.800%		 1,594,667increase
(+62.59%)		 Filing
2022-02-04
4:12 pm
Purchase		 2021-12-31 13G Nurix Therapeutics, Inc.
NRIX		 BlackRock Inc.
BLK		 2,547,861
5.700%		 2,547,861increase
(New Position)		 Filing